back to cluster viewer
cluster path 0001101110
51 words, 17,477 tokens
freq alpha suffix
Words in frequency order
1 | influence | 17,415
|
2 | reordering | 5
|
3 | mid-to | 3
|
4 | meta-analysis.although | 2
|
5 | prebinding | 2
|
6 | results.no | 2
|
7 | ser9-phosphorylation | 2
|
8 | treatment-course | 2
|
9 | usfda | 2
|
10 | 'limitation | 1
|
11 | 'reading | 1
|
12 | 'train | 1
|
13 | abstract.in | 1
|
14 | animals.in | 1
|
15 | better-and | 1
|
16 | cldn5-like | 1
|
17 | clinician-is | 1
|
18 | diagnosis.over | 1
|
19 | effect.. | 1
|
20 | english-born | 1
|
21 | error.among | 1
|
22 | euroscore-with | 1
|
23 | expertise-and | 1
|
24 | gainedflexion | 1
|
25 | gcb/non-gcb | 1
|
26 | host.beyond | 1
|
27 | ibq-scales | 1
|
28 | improved.diversity | 1
|
29 | increased.meta-analysis | 1
|
30 | intervention.for | 1
|
31 | maintenance/improvement | 1
|
32 | meta-analysis.despite | 1
|
33 | micro-quantified | 1
|
34 | morning.in | 1
|
35 | neonates.for | 1
|
36 | organism.in | 1
|
37 | phylum/class-level | 1
|
38 | prim1-study | 1
|
39 | programme/entering | 1
|
40 | pseudo-gem-series | 1
|
41 | registry.conclusion | 1
|
42 | resultsof | 1
|
43 | sarpogrelateor | 1
|
44 | sexes.in | 1
|
45 | strong.objective | 1
|
46 | sumo-1-ylation | 1
|
47 | targetand | 1
|
48 | therapeutant | 1
|
49 | time/length | 1
|
50 | wnt/β- | 1
|
51 | α1-receptor | 1
|
Words in alphabetical order
1 | 'limitation | 1
|
2 | 'reading | 1
|
3 | 'train | 1
|
4 | abstract.in | 1
|
5 | animals.in | 1
|
6 | better-and | 1
|
7 | cldn5-like | 1
|
8 | clinician-is | 1
|
9 | diagnosis.over | 1
|
10 | effect.. | 1
|
11 | english-born | 1
|
12 | error.among | 1
|
13 | euroscore-with | 1
|
14 | expertise-and | 1
|
15 | gainedflexion | 1
|
16 | gcb/non-gcb | 1
|
17 | host.beyond | 1
|
18 | ibq-scales | 1
|
19 | improved.diversity | 1
|
20 | increased.meta-analysis | 1
|
21 | influence | 17,415
|
22 | intervention.for | 1
|
23 | maintenance/improvement | 1
|
24 | meta-analysis.although | 2
|
25 | meta-analysis.despite | 1
|
26 | micro-quantified | 1
|
27 | mid-to | 3
|
28 | morning.in | 1
|
29 | neonates.for | 1
|
30 | organism.in | 1
|
31 | phylum/class-level | 1
|
32 | prebinding | 2
|
33 | prim1-study | 1
|
34 | programme/entering | 1
|
35 | pseudo-gem-series | 1
|
36 | registry.conclusion | 1
|
37 | reordering | 5
|
38 | results.no | 2
|
39 | resultsof | 1
|
40 | sarpogrelateor | 1
|
41 | ser9-phosphorylation | 2
|
42 | sexes.in | 1
|
43 | strong.objective | 1
|
44 | sumo-1-ylation | 1
|
45 | targetand | 1
|
46 | therapeutant | 1
|
47 | time/length | 1
|
48 | treatment-course | 2
|
49 | usfda | 2
|
50 | wnt/β- | 1
|
51 | α1-receptor | 1
|
Words in suffix order
1 | wnt/β- | 1
|
2 | effect.. | 1
|
3 | usfda | 2
|
4 | gcb/non-gcb | 1
|
5 | micro-quantified | 1
|
6 | expertise-and | 1
|
7 | better-and | 1
|
8 | targetand | 1
|
9 | host.beyond | 1
|
10 | influence | 17,415
|
11 | cldn5-like | 1
|
12 | treatment-course | 2
|
13 | meta-analysis.despite | 1
|
14 | strong.objective | 1
|
15 | resultsof | 1
|
16 | 'reading | 1
|
17 | prebinding | 2
|
18 | reordering | 5
|
19 | programme/entering | 1
|
20 | error.among | 1
|
21 | meta-analysis.although | 2
|
22 | time/length | 1
|
23 | euroscore-with | 1
|
24 | phylum/class-level | 1
|
25 | morning.in | 1
|
26 | organism.in | 1
|
27 | sexes.in | 1
|
28 | animals.in | 1
|
29 | abstract.in | 1
|
30 | 'train | 1
|
31 | registry.conclusion | 1
|
32 | sumo-1-ylation | 1
|
33 | ser9-phosphorylation | 2
|
34 | 'limitation | 1
|
35 | gainedflexion | 1
|
36 | english-born | 1
|
37 | results.no | 2
|
38 | mid-to | 3
|
39 | diagnosis.over | 1
|
40 | sarpogrelateor | 1
|
41 | intervention.for | 1
|
42 | neonates.for | 1
|
43 | α1-receptor | 1
|
44 | pseudo-gem-series | 1
|
45 | ibq-scales | 1
|
46 | clinician-is | 1
|
47 | increased.meta-analysis | 1
|
48 | therapeutant | 1
|
49 | maintenance/improvement | 1
|
50 | prim1-study | 1
|
51 | improved.diversity | 1
|